C51H63N11O3S2 — CID 87427905
N-[2-[3-[1H-benzimidazol-2-yl-(1-methylpiperidin-4-yl)oxymethyl]phenyl]sulfanylethyl]-4,5-dihydro-1H-imidazol-2-amine;2-[(1-methylpiperidin-4-yl)oxy-[3-[4-(1,2,4-triazol-1-yl)butoxy]phenyl]methyl]-1,3-benzothiazole (PubChem CID 87427905) has the molecular formula C51H63N11O3S2 and a molecular weight of 942.27 g/mol. Its IUPAC name is N-[2-[3-[1H-benzimidazol-2-yl-(1-methylpiperidin-4-yl)oxymethyl]phenyl]sulfanylethyl]-4,5-dihydro-1H-imidazol-2-amine;2-[(1-methylpiperidin-4-yl)oxy-[3-[4-(1,2,4-triazol-1-yl)butoxy]phenyl]methyl]-1,3-benzothiazole.
| Compound Name | N-[2-[3-[1H-benzimidazol-2-yl-(1-methylpiperidin-4-yl)oxymethyl]phenyl]sulfanylethyl]-4,5-dihydro-1H-imidazol-2-amine;2-[(1-methylpiperidin-4-yl)oxy-[3-[4-(1,2,4-triazol-1-yl)butoxy]phenyl]methyl]-1,3-benzothiazole |
|---|---|
| PubChem CID | 87427905 |
| Molecular Formula | C51H63N11O3S2 |
| Molecular Weight | 942.27 g/mol |
| Exact Mass | 941.46 |
| IUPAC Name | N-[2-[3-[1H-benzimidazol-2-yl-(1-methylpiperidin-4-yl)oxymethyl]phenyl]sulfanylethyl]-4,5-dihydro-1H-imidazol-2-amine;2-[(1-methylpiperidin-4-yl)oxy-[3-[4-(1,2,4-triazol-1-yl)butoxy]phenyl]methyl]-1,3-benzothiazole |
| SMILES | CN1CCC(OC(c2cccc(OCCCCn3cncn3)c2)c2nc3ccccc3s2)CC1.CN1CCC(OC(c2cccc(SCCNC3=NCCN3)c2)c2nc3ccccc3[nH]2)CC1 |
| InChI | InChI=1S/C26H31N5O2S.C25H32N6OS/c1-30-14-11-21(12-15-30)33-25(26-29-23-9-2-3-10-24(23)34-26)20-7-6-8-22(17-20)32-16-5-4-13-31-19-27-18-28-31;1-31-14-9-19(10-15-31)32-23(24-29-21-7-2-3-8-22(21)30-24)18-5-4-6-20(17-18)33-16-13-28-25-26-11-12-27-25/h2-3,6-10,17-19,21,25H,4-5,11-16H2,1H3;2-8,17,19,23H,9-16H2,1H3,(H,29,30)(H2,26,27,28) |
| InChIKey | PIVZWSFEHXHEFL-UHFFFAOYSA-N |
| XLogP | 8.35 |
| TPSA | 142.87 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 67 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 942.27 |
| LogP ≤ 5 | 8.35 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 15 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|